FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Stimulator, Autonomic Nerve, Implanted For Stroke Rehabilitation

PMA: P210007 · Supplement: S006 · Decision May 30, 2025
Classifications
1
FEI Numbers
7
Registration Numbers
7

Basic Information

Device Name
Stimulator, Autonomic Nerve, Implanted For Stroke Rehabilitation
Trade Name
Vivistim® System
PMA Number
P210007
Supplement Number
S006
Device Class
FDA Class 3
Product Code
QPY
Generic Name
Stimulator, autonomic nerve, implanted for stroke rehabilitation
Medical Specialty
Unknown
Advisory Committee
Physical Medicine
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
May 30, 2025
Date Received
May 1, 2025
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

Approval for proposed manufacturing changes, consisting of changes in suppliers of selected components internal to the ViviStim Implantable Pulse Generator (IPG). These component suppliers were previously qualified by the main contract manufacturer and included on their Approved Suppliers List for the supply of raw materials and unfinished components, and they are now qualified to perform additional manufacturing steps that were previously performed by the main contract manufacturer.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
QPY Stimulator, Autonomic Nerve, Implanted For Stroke Rehabilitation